Martin O'Malley

Martin O'Malley's policies onHealthcare

Invest in NIH and FDA research

O’Malley will double the NIH budget will promote the next generation of transformative products. A substantial portion of this increase will be set aside to support innovative research occurring within U.S. small drug or device companies. At the same time, O’Malley will provide greater funding to the FDA to allow the agency to foster new and more efficient ways to review new products. O’Malley will also reduce the hidden tax on biotech development that exists in the form of industry assessments for the reviews of their products.

Found an error or want to make a contribution?